Further, our observation that the sensitivity to DTX in chemoresistant PCa cells was significantly augmented when EXI and RELA were used in combination with LEDGF/p75 silencing suggests that combining LEDGF/p75 inhibitors with these SMGRs could be an effective therapeutic strategy to increase prostate tumor response to taxanes. This evidence concerns the gene RELA and posterior cortical atrophy.